← Back to Clinical Trials
Recruiting NCT07004881

NCT07004881 Comparison Between the Effects of Mulligan and Maitland Mobilization on Patellofemoral Pain Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07004881
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Patellofemoral Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-07-15
Primary Completion 2025-07-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Group A (Active Comparator) Mulligan's Mobilization With Movement (MWM)Group B(Experimental) Maitland's Patellar Mobilizations

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-07-15 with a primary completion date of 2025-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a randomised control trial and the purpose of this study is to investigate and compare the "Effects of Maitland mobilizations and Mulligan Mobilization With Movement (MWM) in patients with Patellofemoral Pain Syndrome

Eligibility Criteria

Inclusion Criteria: * Referred patients from rehabilitation, orthopedic and rheumatology department * Both males and females of age 18-40 years * Having pain from at least 2 months. * Pain score ≥ 3 on NPRS. * Pain on palpation of medial or lateral Patellar facet. (12, 13) * Retro patellar pain in at least two of the following activities: * Ascending , descending stairs * Hopping / jumping * prolonged sitting with flexed knees * kneeling and squatting * Patellar tilt test * EXCLUSION CRIETERIA: * Positive tests/findings on physical examination for knee menisci, ligaments and bursa. * Chondromalacia patellae * Individuals with Instability of tibiofemoral joint * lower extremity surgery * Rheumatoid arthritis, other connective tissue disorders and congenital deformities.

Contact & Investigator

Central Contact

Anza Moiz, DPT

✉ anzamoiz31@gmail.com

📞 +923350511715

Frequently Asked Questions

Who can join the NCT07004881 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Patellofemoral Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07004881 currently recruiting?

Yes, NCT07004881 is actively recruiting participants. Contact the research team at anzamoiz31@gmail.com for enrollment information.

Where is the NCT07004881 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07004881 clinical trial?

NCT07004881 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology